Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Kei Moriya, Tadashi Namisaki, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji

Clin Mol Hepatol. 2019;25(4):381-389. Published online August 13, 2019

DOI: https://doi.org/10.3350/cmh.2019.0037

View: 5058 Download: 134 Citations: 10

Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis

Hyun Young Woo, Jun Mo Youn, Si Hyun Bae, Jeong Won Jang, Jung Hoon Cha, Hye Lim Kim, Ho Jong Chun, Byung Gil Choi, Jong Young Choi, Seoung Kew Yoon

Clin Mol Hepatol. 2012;18(1):32-40. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.32

View: 7022 Download: 43 Citations: 11

3

Efficacy of Hepatic Arterial Infusion Therapy for Advanced Hepatocellular Carcinoma Using 5-fluorouracil and Cisplatin

Byoung Kuk Jang , Ki Min Kwon , Woo Jin Chung , Kyung Sik Park , Kwang Bum Cho , Jae Seok Hwang , Sung Hoon Ahn , Gab Chul Kim , Young Hwan Kim , Jin Soo Choi , Jung Hye

Clin Mol Hepatol. 2004;10(4):271-278.

View: 2318 Download: 27

Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis

Jin Suk Kim, M.D., Kwang-Hyub Han, M.D., Do Yun Lee, M.D.* , Jin-Sil Seong, M.D.† , Young Hoon Youn, M.D., Jae Youn Cheong, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(1):71-79. Published online January 1, 1970

View: 2762 Download: 19

1 |

Viewed By 5424	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4831	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 4195	MAFLD: How is it different from NAFLD?
Viewed By 3974	A decade of liver organoids: Advances in disease modeling
Viewed By 2988	Management of refractory ascites

Cited By 128	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 77	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 57	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 55	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 51	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Search